Sullivan Eddie Joe
SEC CIK 1889712 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics, Inc. | CEO, Dir, 10% | 5.23M | $11.9K | — | 3 | 2021-10-07 | 2023-12-07 |
Most active insiders at SABS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moin Andrew | Dir | — | — |
| 2 | Kropotova Alexandra | Chief MEDICAL Off | — | — |
| 3 | Sessa Capital GP, LLC | Dir | — | — |
Sullivan Eddie Joe made no open-market trades at SABS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-08 | 2023-12-07 | SABS | SAB Biotherapeutics, Inc. | Sullivan Eddie Joe | CEO, Dir | P - Purchase | $0.88 | +1,740 | 5.23M | +0.0% | +$1,531 | |
| 2022-09-08 | 2022-09-07 | SABS | SAB Biotherapeutics, Inc. | Sullivan Eddie Joe | CEO, Dir, 10% | P - Purchase | $0.74 | +14.0K | 5.23M | +0.3% | +$10.4K | |
| DM | 2021-10-26 | 2021-10-07+ | SABS | SAB Biotherapeutics, Inc. | Sullivan Eddie Joe | CEO, Dir, 10% | A - Grant | $10.07 | +5.22M | 2,800 | New | +$52.53M |
Purchase Sale Sale after option exercise All abbreviations